222 related articles for article (PubMed ID: 18829500)
1. Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions.
Su Z; Frye C; Bae KM; Kelley V; Vieweg J
Clin Cancer Res; 2008 Oct; 14(19):6207-17. PubMed ID: 18829500
[TBL] [Abstract][Full Text] [Related]
2. The immunogenicity of dendritic cell-derived exosomes.
Quah BJ; O'Neill HC
Blood Cells Mol Dis; 2005; 35(2):94-110. PubMed ID: 15975838
[TBL] [Abstract][Full Text] [Related]
3. Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.
Nishimoto KP; Tseng SY; Lebkowski JS; Reddy A
Regen Med; 2011 May; 6(3):303-18. PubMed ID: 21548736
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.
Zhong RK; Loken M; Lane TA; Ball ED
Cytotherapy; 2006; 8(1):3-12. PubMed ID: 16627340
[TBL] [Abstract][Full Text] [Related]
5. Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses.
Warncke M; Dodero A; Dierbach H; Follo M; Veelken H
J Immunol Methods; 2006 Mar; 310(1-2):1-11. PubMed ID: 16337648
[TBL] [Abstract][Full Text] [Related]
6. Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions.
Choo A; Ngo AS; Ding V; Oh S; Kiang LS
Methods Cell Biol; 2008; 86():15-28. PubMed ID: 18442642
[TBL] [Abstract][Full Text] [Related]
7. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function.
Senju S; Suemori H; Zembutsu H; Uemura Y; Hirata S; Fukuma D; Matsuyoshi H; Shimomura M; Haruta M; Fukushima S; Matsunaga Y; Katagiri T; Nakamura Y; Furuya M; Nakatsuji N; Nishimura Y
Stem Cells; 2007 Nov; 25(11):2720-9. PubMed ID: 17690179
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.
Balkow S; Loser K; Krummen M; Higuchi T; Rothoeft T; Apelt J; Tuettenberg A; Weishaupt C; Beissert S; Grabbe S
Exp Dermatol; 2009 Jan; 18(1):78-87. PubMed ID: 19054060
[TBL] [Abstract][Full Text] [Related]
9. Directed differentiation of human embryonic stem cells to dendritic cells.
Vodyanik MA; Slukvin II
Methods Mol Biol; 2007; 407():275-93. PubMed ID: 18453262
[TBL] [Abstract][Full Text] [Related]
10. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
[TBL] [Abstract][Full Text] [Related]
11. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
12. A feeder-free and efficient production of functional neutrophils from human embryonic stem cells.
Saeki K; Saeki K; Nakahara M; Matsuyama S; Nakamura N; Yogiashi Y; Yoneda A; Koyanagi M; Kondo Y; Yuo A
Stem Cells; 2009 Jan; 27(1):59-67. PubMed ID: 18845766
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma, as secreted during an alloresponse, induces differentiation of monocytes into tolerogenic dendritic cells, resulting in FoxP3+ regulatory T cell promotion.
Eljaafari A; Li YP; Miossec P
J Immunol; 2009 Sep; 183(5):2932-45. PubMed ID: 19696431
[TBL] [Abstract][Full Text] [Related]
14. Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cells by CD1d overexpression.
Zeng J; Shahbazi M; Wu C; Toh HC; Wang S
J Immunol; 2012 May; 188(9):4297-304. PubMed ID: 22407918
[TBL] [Abstract][Full Text] [Related]
15. A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells.
Balan S; Kale VP; Limaye LS
Transfusion; 2009 Oct; 49(10):2109-21. PubMed ID: 19497054
[TBL] [Abstract][Full Text] [Related]
16. Highly phagocytic, CD4hi, CD14hi and CD16hi antigen-presenting cells modulated by tumour-conditioned media retain the capacity to mature and induce TH1 T-cell proliferation.
Metharom P; Velten FW; Goerdt S
Mol Immunol; 2006 May; 43(13):2070-82. PubMed ID: 16455138
[TBL] [Abstract][Full Text] [Related]
17. Numerical and functional assessment of blood dendritic cells in prostate cancer patients.
Wilkinson R; Kassianos AJ; Swindle P; Hart DN; Radford KJ
Prostate; 2006 Feb; 66(2):180-92. PubMed ID: 16173035
[TBL] [Abstract][Full Text] [Related]
18. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
[TBL] [Abstract][Full Text] [Related]
19. Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device.
Perseghin P; D'Amico G; Dander E; Gaipa G; Dassi M; Biagi E; Biondi A
Transfusion; 2008 Aug; 48(8):1644-9. PubMed ID: 18513258
[TBL] [Abstract][Full Text] [Related]
20. Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.
Tseng SY; Nishimoto KP; Silk KM; Majumdar AS; Dawes GN; Waldmann H; Fairchild PJ; Lebkowski JS; Reddy A
Regen Med; 2009 Jul; 4(4):513-26. PubMed ID: 19580370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
